Satisfai Health Purchases Assets of Docbot, Inc.

Solidifies Satisfai as one of the leading technology companies globally in artificial intelligence for gastroenterology

Satisfai Health Inc today announces its strategic acquisition of Docbot Inc’s portfolio of Intellectual Property and Assets which is complementary and accretive to Satisfai’s products and technology stack, focused in the field of artificial intelligence (AI) as applied to gastrointestinal endoscopy. In addition, key Docbot technical employees have been transferred to Satisfai Health.

Previous
Previous

Satisfai Leads Panel at 2023 AGA Tech Summit

Next
Next

Alimentiv, Satisfai Health, and Virgo Announce Partnership to use AI driven technology to Enhance Clinical Trials in IBD and other GI Diseases